For decades, scientists have investigated the neurokinin-1 receptor (NK1R) as a potential target for treating major depressive disorder. Early studies suggested promise, but enthusiasm faded after ...
Machine-learning–guided screening identified a structurally novel NK1 receptor antagonist that reduced depressive-like ...
For decades, scientists have investigated the neurokinin-1 receptor (NK1R) as a potential target for treating major ...